Exton, PA, United States of America

Adolor Corporation


USPTO Granted Patents = 69

% Expired Patents = 43.5



Trademarks = 1

Forward Citations = 898

Loading Chart...
Loading Chart...

38 inventors (with patents filed for the assignee):

goldMedal Roland Ellwood Dolle (29 out of 81 patents)

silverMedal Virendra Kumar (26 out of 52 patents)

bronzeMedal Bertrand Le Bourdonnec (23 out of 26 patents)

4.  Alan L Maycock (23 out of 26 patents)

5.  John J Farrar (22 out of 24 patents)

6.  Wei Yuan Zhang (22 out of 23 patents)

7.  An-Chih Chang (20 out of 22 patents)

8.  Michael Anthony Marella (17 out of 17 patents)

9.  Forrest Gaul (17 out of 17 patents)

10.  Lawrence I Kruse (10 out of 45 patents)

11.  Diane L DeHaven-Hudkins (10 out of 21 patents)

12.  Deqi Guo (9 out of 21 patents)

13.  Guo-Hua Chu (6 out of 12 patents)

14.  Alan Cowan (5 out of 9 patents)

15.  Allan James Goodman (4 out of 5 patents)


Core Competencies:
Opioid Antagonists
Drug Delivery
Gastrointestinal Dysfunction
Piperidine Compounds
Spirocyclic Derivatives
Kappa Agonists
Analgesics
Anti-Pruritic
Pharmaceutical Formulations
Treatment Methods
Pain Management
Cytokine Inhibitors

69 patents:

Adolor Corporation, based in Exton, PA, specializes in the development of innovative opioid antagonists aimed at addressing gastrointestinal dysfunction and pain management. The company focuses on advanced drug delivery systems and the design of piperidine compounds and spirocyclic derivatives. With a commitment to improving patient outcomes, Adolor's research encompasses various therapeutic areas, including analgesics and anti-pruritic solutions, leveraging its expertise in kappa agonists to create effective treatments.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Adolor Corporation
69 Patents

#5 in Exton, PA

#204 in Pennsylvania

#5,302 in US

#10,751 in the World

Exton, PA (US)
Exton, PA, United States of America
Forward Citations = 898

38 inventors:

Please report any incorrect information to [email protected]
Loading…